Published in Radiother Oncol on May 01, 1998
An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat (2007) 2.65
BRCA mutations in the management of breast cancer: the state of the art. Nat Rev Clin Oncol (2010) 1.32
The role of BRCA mutation testing in determining breast cancer therapy. Nat Rev Clin Oncol (2010) 1.18
Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery. BMC Womens Health (2010) 0.94
Contralateral breast cancer after radiotherapy among BRCA1 and BRCA2 mutation carriers: a WECARE study report. Eur J Cancer (2013) 0.90
Molecular genetics of solid tumours: translating research into clinical practice. What we could do now: breast cancer. Mol Pathol (2001) 0.87
A bioinformatics filtering strategy for identifying radiation response biomarker candidates. PLoS One (2012) 0.86
Expression of estrogen receptor beta in the breast carcinoma of BRCA1 mutation carriers. BMC Cancer (2008) 0.84
The Role of PARP Inhibitors in the Treatment of Gynecologic Malignancies. Front Oncol (2013) 0.84
Worse breast cancer prognosis of BRCA1/BRCA2 mutation carriers: what's the evidence? A systematic review with meta-analysis. PLoS One (2015) 0.78
Prophylactic and Therapeutic Breast Conservation in BRCA1/2 Mutation Carriers. Int J Breast Cancer (2011) 0.77
BRCA mutations and survival in breast cancer: an updated systematic review and meta-analysis. Oncotarget (2016) 0.77
Survival in Norwegian BRCA1 mutation carriers with breast cancer. Hered Cancer Clin Pract (2009) 0.76
Prognostic value of BRCA1 mutations in familial breast cancer patients affected by a second primary cancer. Fam Cancer (2007) 0.75
Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials (2000) 10.99
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science (1994) 8.73
The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet (1996) 6.43
Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst (1994) 6.27
A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet (2001) 5.06
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet (2000) 3.50
Shared genomic segment analysis. Mapping disease predisposition genes in extended pedigrees using SNP genotype assays. Ann Hum Genet (2007) 3.46
Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst (1999) 3.26
Genomic mismatch scanning in pedigrees. IMA J Math Appl Med Biol (1994) 3.16
Right aortic arch: plain film diagnosis and significance. Am J Roentgenol Radium Ther Nucl Med (1966) 3.14
Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol Psychiatry (2010) 2.95
Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science (1992) 2.89
BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing. JAMA (1997) 2.78
Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet (1997) 2.77
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary. J Med Genet (2005) 2.65
Meta-analysis of genome searches. Ann Hum Genet (1999) 2.27
Outbreak of Brucella melitensis among microbiology laboratory workers in a community hospital. J Clin Microbiol (1991) 2.20
Predicting treatment response in psoriasis using serum levels of adalimumab and etanercept: a single-centre, cohort study. Br J Dermatol (2013) 2.10
Meta-analysis of 32 genome-wide linkage studies of schizophrenia. Mol Psychiatry (2008) 2.07
Therapygenetics: the 5HTTLPR and response to psychological therapy. Mol Psychiatry (2011) 2.06
Rare mutations in XRCC2 increase the risk of breast cancer. Am J Hum Genet (2012) 2.06
Regulation of nitrate reductase in the basidiomycete Ustilago maydis. J Bacteriol (1970) 2.00
Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med (1981) 1.99
Early history of lipoplasty in the United States. Aesthetic Plast Surg (1990) 1.96
Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study. Lancet (2001) 1.87
Modification of BRCA1- and BRCA2-associated breast cancer risk by AIB1 genotype and reproductive history. Cancer Res (2001) 1.81
Inverse relationship between microsatellite instability and K-ras and p53 gene alterations in colon cancer. Am J Pathol (2001) 1.79
The potentiating effects of alcohol on driver injury. JAMA (1986) 1.75
The effect of family structure on linkage tests using allelic association. Am J Hum Genet (1998) 1.73
Novel pharmacogenetic markers for treatment outcome in azathioprine-treated inflammatory bowel disease. Aliment Pharmacol Ther (2009) 1.72
A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis. J Natl Cancer Inst (1994) 1.69
Survival of subendocardial Purkinje fibers after extensive myocardial infarction in dogs. Circ Res (1973) 1.65
DNA sequence variation within maize and melon: observations from polymerase chain reaction amplification and direct sequencing. Genetics (1990) 1.64
DNA variation in a 5-Mb region of the X chromosome and estimates of sex-specific/type-specific mutation rates. Am J Hum Genet (1999) 1.64
A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol (1994) 1.64
Aneurysmal bone cyst: an analysis of ninety-five cases. Mayo Clin Proc (1968) 1.64
Derivation of clones from the choroideremia locus by preparative field inversion gel electrophoresis. Nucleic Acids Res (1990) 1.63
Mutation of Tec family kinases alters T helper cell differentiation. Nat Immunol (2001) 1.63
Preservation of RNA for functional genomic studies: a multidisciplinary tumor bank protocol. Mod Pathol (2001) 1.63
Motorcycle trauma in the state of Illinois: analysis of the Illinois Department of Public Health Trauma Registry. Ann Emerg Med (1995) 1.62
Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B. Am J Hum Genet (1999) 1.61
Tumor development in the Beckwith-Wiedemann syndrome is associated with a variety of constitutional molecular 11p15 alterations including imprinting defects of KCNQ1OT1. Hum Mol Genet (2001) 1.58
Proliferation and cellular phenotype in lymphomatoid granulomatosis: implications of a higher proliferation index in B cells. Am J Surg Pathol (1998) 1.57
Cognitive test performance and crash risk in an older driver population. Accid Anal Prev (1998) 1.55
Meta-analysis of genome-wide linkage studies of systemic lupus erythematosus. Genes Immun (2006) 1.54
Breast cancer after mantle irradiation for Hodgkin's disease: correlation of clinical, pathologic, and molecular features including loss of heterozygosity at BRCA1 and BRCA2. Int J Radiat Oncol Biol Phys (2001) 1.53
Heart disease following radiation. Medicine (Baltimore) (1967) 1.53
Fusion of intracellular membrane pools with cell surfaces of macrophages stimulated by phorbol esters and calcium ionophores. Cell (1984) 1.51
Expression of DNA toposiomerase I and DNA topoisomerase II-alpha in testicular seminomas. Hum Pathol (2000) 1.49
Accuracy of tympanic and infrared skin thermometers in children. Arch Dis Child (2010) 1.48
Pathogenesis of radiation-induced myocardial fibrosis. Lab Invest (1973) 1.45
Identification of a 14 kb deletion involving the promoter region of BRCA1 in a breast cancer family. Hum Mol Genet (1997) 1.44
Radiation-induced heart disease. Clinical and experimental aspects. Radiol Clin North Am (1971) 1.42
Inflammatory tumour cell killing by oncolytic reovirus for the treatment of melanoma. Gene Ther (2008) 1.41
Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics (1996) 1.41
Spin correlations in the paramagnetic phase and ring exchange in La2CuO4. Phys Rev Lett (2005) 1.40
Replication of celiac disease UK genome-wide association study results in a US population. Hum Mol Genet (2009) 1.39
Methotrexate polyglutamates as a marker of patient compliance and clinical response in psoriasis: a single-centre prospective study. Br J Dermatol (2012) 1.39
Change in injuries associated with safety belt laws. Accid Anal Prev (1991) 1.39
Psychological considerations in lipoplasty: the problematic or "special care" patient. Ann Plast Surg (1989) 1.38
Reduction of myocardial ischemic injury with oxygen-derived free radical scavengers. Surgery (1983) 1.38
High allele loss rates at 17q12-q21 in breast and ovarian tumors from BRCAl-linked families. The Breast Cancer Linkage Consortium. Genes Chromosomes Cancer (1995) 1.34
The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers. Br J Cancer (2012) 1.34
The risk of subsequent primary cancers after colorectal cancer in southeast England. Gut (2002) 1.34
Meta-analysis of four rheumatoid arthritis genome-wide linkage studies: confirmation of a susceptibility locus on chromosome 16. Arthritis Rheum (2003) 1.32
Mistranslation and ageing in Neurospora. Nature (1970) 1.31
Incidence of multiple primary cancers in a cohort of women diagnosed with breast cancer in southeast England. Br J Cancer (2001) 1.30
Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy. Chest (1996) 1.29
Beta adrenergic blockade. Hemodynamics and myocardial energy metabolism in patients with ischemic heart disease. Am J Cardiol (1968) 1.28
Quantitative methods in research on complementary and alternative medicine. A methodological manifesto. NIH Office of Alternative Medicine. Med Care (1997) 1.28
Knowledge, attitudes, and interest in breast-ovarian cancer gene testing: a survey of a large African-American kindred with a BRCA1 mutation. Prev Med (2001) 1.27
Analysis of discrete phenotypes using a multipoint identity-by-descent method: application to Alzheimer's disease. Genet Epidemiol (1993) 1.27
Human DNA topoisomerase II-alpha: a new marker of cell proliferation in invasive breast cancer. Hum Pathol (1997) 1.26
Surveillance for chronic fatigue syndrome--four U.S. cities, September 1989 through August 1993. MMWR CDC Surveill Summ (1997) 1.25
Inheritance of proliferative breast disease in breast cancer kindreds. Science (1990) 1.24
Familiality of diabetes mellitus. Exp Clin Endocrinol Diabetes (2007) 1.24
Human hypoxanthine-guanine phosphoribosyltransferase. Evidence for tetrameric structure. J Biol Chem (1978) 1.24
Chromosome 17q linkage studies of 18 Utah breast cancer kindreds. Am J Hum Genet (1993) 1.23
SNP subset selection for genetic association studies. Ann Hum Genet (2003) 1.22
Pharmacogenetic variants in the DPYD, TYMS, CDA and MTHFR genes are clinically significant predictors of fluoropyrimidine toxicity. Br J Cancer (2013) 1.19
Measles virus causes immunogenic cell death in human melanoma. Gene Ther (2011) 1.19
Oxidant-induced S-glutathiolation inactivates protein kinase C-alpha (PKC-alpha): a potential mechanism of PKC isozyme regulation. Biochemistry (2000) 1.19
Electrophysiologic and antiarrhythmic effects of phentolamine in experimental coronary artery occlusion and reperfusion in the dog. J Cardiovasc Pharmacol (1980) 1.18
Immune responses associated with chronic fatigue syndrome: a case-control study. J Infect Dis (1997) 1.17
Colonic work-up after incomplete colonoscopy: significant new findings during follow-up. Endoscopy (2010) 1.16
Experimental radiation-induced heart disease. I. Light microscopic studies. Am J Pathol (1970) 1.16
Prevalence and clinical characteristics of celiac disease in Downs syndrome in a US study. Am J Med Genet (2001) 1.16
Hemorrhage vs rethrombosis after thrombolysis for acute myocardial infarction. Arch Intern Med (1986) 1.14
Genome-wide association study of increasing suicidal ideation during antidepressant treatment in the GENDEP project. Pharmacogenomics J (2010) 1.14
Power comparisons of the transmission/disequilibrium test and sib-transmission/disequilibrium-test statistics. Am J Hum Genet (1999) 1.13
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. Oncogene (2011) 1.12
Radiation-induced heart disease: an update. Prog Cardiovasc Dis (1984) 1.12
Longitudinal study of dental health behaviors and other caries predictors in early childhood. Community Dent Oral Epidemiol (1988) 1.12
Correlation of SMNt and SMNc gene copy number with age of onset and survival in spinal muscular atrophy. Eur J Hum Genet (1999) 1.12